Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.

Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, Smith MA.

J Clin Oncol. 2011 Nov 20;29(33):4401-9. doi: 10.1200/JCO.2011.36.4414. Epub 2011 Oct 3.

2.

Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.

Weiss JM, Schumacher J, Allen GO, Neuman H, Lange EO, Loconte NK, Greenberg CC, Smith MA.

Ann Surg Oncol. 2014 Jun;21(6):1781-91. doi: 10.1245/s10434-014-3631-8. Epub 2014 Mar 19.

3.

Is there a difference in survival between right- versus left-sided colon cancers?

Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N.

Ann Surg Oncol. 2008 Sep;15(9):2388-94. doi: 10.1245/s10434-008-0015-y. Epub 2008 Jul 12.

4.

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

O'Connor ES, Greenblatt DY, LoConte NK, Gangnon RE, Liou JI, Heise CP, Smith MA.

J Clin Oncol. 2011 Sep 1;29(25):3381-8. doi: 10.1200/JCO.2010.34.3426. Epub 2011 Jul 25.

5.

Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.

Hanna N, Bikov KA, McNally D, Onwudiwe NC, Dalal M, Mullins CD.

Oncologist. 2012;17(9):1191-7. Epub 2012 Jul 5.

6.

Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?

Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA.

J Am Coll Surg. 2012 Sep;215(3):400-11. doi: 10.1016/j.jamcollsurg.2012.05.014. Epub 2012 Jun 8.

PMID:
22683070
7.

Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS.

J Natl Cancer Inst. 2005 Mar 16;97(6):419-24.

8.

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, McCleary NJ, Meyerhardt JA, Niland J, Kahn KL, Schymura MJ, Schrag D.

J Clin Oncol. 2012 Jul 20;30(21):2624-34. doi: 10.1200/JCO.2011.41.1140. Epub 2012 Jun 4.

9.

Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.

Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H; Colon/Rectum Carcinomas (Primary Tumor) Study Group.

Dis Colon Rectum. 2010 Jan;53(1):57-64. doi: 10.1007/DCR.0b013e3181c703a4.

PMID:
20010352
10.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

11.

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.

Huang CW, Tsai HL, Huang MY, Huang CM, Yeh YS, Ma CJ, Wang JY.

World J Surg Oncol. 2015 Aug 28;13:257. doi: 10.1186/s12957-015-0640-4.

12.

Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.

Hsiao FY, Mullins CD, Onukwugha E, Pandya N, Hanna N.

J Am Geriatr Soc. 2011 Sep;59(9):1717-23. doi: 10.1111/j.1532-5415.2011.03501.x. Epub 2011 Aug 10.

PMID:
21831168
13.

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Hanna NN, Onukwugha E, Choti MA, Davidoff AJ, Zuckerman IH, Hsu VD, Mullins CD.

Colorectal Dis. 2012 Jan;14(1):48-55. doi: 10.1111/j.1463-1318.2011.02545.x.

PMID:
21689262
14.

Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.

Thirunavukarasu P, Talati C, Munjal S, Attwood K, Edge SB, Francescutti V.

JAMA Surg. 2015 Aug;150(8):747-55. doi: 10.1001/jamasurg.2015.0871.

PMID:
26083632
15.

Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.

Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T.

Int J Surg. 2014;12(9):925-30. doi: 10.1016/j.ijsu.2014.07.270. Epub 2014 Aug 1.

16.
17.

Difference in Time to Locoregional Recurrence Between Patients With Right-Sided and Left-Sided Colon Cancers.

Park JH, Kim MJ, Park SC, Kim MJ, Hong CW, Sohn DK, Han KS, Oh JH.

Dis Colon Rectum. 2015 Sep;58(9):831-7. doi: 10.1097/DCR.0000000000000426.

PMID:
26252844
18.

Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.

Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME.

JAMA. 2006 Dec 20;296(23):2815-22.

PMID:
17179458
19.

Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.

McCarthy EP, Ngo LH, Chirikos TN, Roetzheim RG, Li D, Drews RE, Iezzoni LI.

Health Serv Res. 2007 Apr;42(2):611-28.

20.

Outcome of right- and left-sided colonic and rectal cancer following surgical resection.

Suttie SA, Shaikh I, Mullen R, Amin AI, Daniel T, Yalamarthi S.

Colorectal Dis. 2011 Aug;13(8):884-9. doi: 10.1111/j.1463-1318.2010.02356.x. Epub 2010 Jun 28.

PMID:
20594201
Items per page

Supplemental Content

Write to the Help Desk